NEW YORK, May 24 (GenomeWeb News) - An analyst at Pacific Growth Equities upgraded Illumina stock yesterday to "buy" from "neutral" after the company on Firday said it will sell 3.5 million shares of its common stock.


As GenomeWeb News reported last week, Illumina expects to pocket around $83.6 million from the sale.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.